A. Gifford

发表

Unique microbial communities persist in individual cystic fibrosis patients throughout a clinical exacerbation

Deborah A Hogan, M. Sogin, H. Morrison, 2013, Microbiome.

Design and Implementation of a Novel Electronic Health Record Tool to Enhance the Care of Individuals with Cystic Fibrosis: The Cystic Fibrosis Note Template

Jennifer A Snide, E. Nelson, A. V. Van Citters, 2019, ACI Open.

CFTR Modulator Use Is Associated with Higher Hemoglobin Levels in Individuals with Cystic Fibrosis

C. Goss, S. Heltshe, A. Gifford, 2019, Annals of the American Thoracic Society.

Iron supplementation does not worsen respiratory health or alter the sputum microbiome in cystic fibrosis.

M. Sogin, G. O’Toole, B. Stanton, 2014, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Noninvasive ventilation as a palliative measure

A. Gifford, 2014, Current Opinion in Supportive and Palliative Care.

A pilot study of cystic fibrosis exacerbation response phenotypes reveals contrasting serum and sputum iron trends

Molly A. Williams, Dana B. Dorman, D. Polineni, 2021, Scientific Reports.

Inflammation in CF: Key Characteristics and Therapeutic Discovery

D. Nichols, D. Polineni, A. Gifford, 2020 .

Answering the call to address cystic fibrosis treatment burden in the era of highly effective CFTR modulator therapy.

D. Nichols, N. Mayer-Hamblett, A. Gifford, 2019, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Respiratory function in an obese patient with sleep-disordered breathing.

J. Leiter, H. Manning, A. Gifford, 2010, Chest.

Availability of Zinc Impacts Interactions between Streptococcus sanguinis and Pseudomonas aeruginosa in Coculture

G. O’Toole, T. Hampton, Kewei Li, 2019, Journal of bacteriology.

Availability of Zinc Impacts Interactions between Streptococcus sanguinis and Pseudomonas aeruginosa in Coculture

G. O’Toole, T. Hampton, Kewei Li, 2019, bioRxiv.

Comparison of dry powder versus nebulized beta-agonist in patients with COPD who have suboptimal peak inspiratory flow rate.

D. Mahler, L. A. Waterman, J. Ward, 2014, Journal of aerosol medicine and pulmonary drug delivery.

The epidemiology of idiopathic pulmonary fibrosis and interstitial lung diseases at risk of a progressive-fibrosing phenotype

T. Suda, A. Olson, N. Inase, 2018, European Respiratory Review.

Evaluating the Impact of Stopping Chronic Therapies after Modulator Drug Therapy in Cystic Fibrosis: The SIMPLIFY Clinical Trial Study Design

J. Clancy, G. Sawicki, K. Riekert, 2021, Annals of the American Thoracic Society.

Mechanism of greater oxygen desaturation during walking compared with cycling in patients with COPD.

J. Baird, D. Mahler, L. A. Waterman, 2011, Chest.

Neuromodulatory Effect of Endogenous Opioids on the Intensity and Unpleasantness of Breathlessness during Resistive Load Breathing in COPD

J. Baird, W. Kraemer, B. Kupchak, 2011, COPD.

Long-term safety of glycopyrrolate: A randomized study in patients with moderate-to-severe COPD (GEM3).

D. Mahler, A. Satti, A. Gifford, 2016, Respiratory medicine.

Effect of increased blood levels of β-endorphin on perception of breathlessness.

W. Kraemer, A. Harver, B. Kupchak, 2013, Chest.

Complications of long and intermediate term venous catheters in cystic fibrosis patients: A multicenter study.

Christine W. Duarte, M. Napier, T. Lahiri, 2018, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Evaluating barriers to and promoters of telehealth during the COVID-19 pandemic at U.S. cystic fibrosis programs

G. Sawicki, P. Scalia, A. V. Van Citters, 2021, Journal of Cystic Fibrosis.

Psychological Factors as Determinants of Noninvasive Continuous Positive Airway Pressure Response: Key Practical Aspects and Topics

A. Gifford, 2016 .

Long-term safety of glycopyrrolate : A randomized study in patients with moderate-to-severe COPD ( GEM 3 )

D. Mahler, A. Satti, A. Gifford, 2016 .

What is hepcidin telling us about the natural history of cystic fibrosis?

A. Gifford, 2015, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Chapter 19 – Dyspnea

D. Mahler, A. Gifford, 2012 .

Prevalence and COPD phenotype for a suboptimal peak inspiratory flow rate against the simulated resistance of the Diskus® dry powder inhaler.

D. Mahler, L. A. Waterman, Laurie A. Waterman, 2013, Journal of aerosol medicine and pulmonary drug delivery.

Serum Iron Level Is Associated with Time to Antibiotics in Cystic Fibrosis

T. Mackenzie, Dana B. Dorman, L. A. Moulton, 2015, Clinical and translational science.

Serum and Sputum Iron Trends Distinguigh Responders and Non-Responders to Treatment of Cystic Fibrosis Pulmonary Exacerbation

Molly A. Williams, Dana B. Dorman, D. Polineni, 2020 .

Risk factors for Clostridium difficile-associated diarrhea on an adult hematology-oncology ward

A. Gifford, K. Kirkland, 2006, European Journal of Clinical Microbiology and Infectious Diseases.

Serum insulin‐like growth factor‐1 (IGF‐1) during CF pulmonary exacerbation: Trends and biomarker correlations

A. Ashare, A. Nymon, A. Gifford, 2014, Pediatric pulmonology.

The role for neutrophil extracellular traps in cystic fibrosis autoimmunity.

M. Mamula, A. Ashare, A. Gifford, 2016, JCI insight.

An Unusual Cause of Endobronchial Obstruction

J. Schwartzman, A. Gifford, Mitsuo Matsuoka, 2009, Respiration.

Iron Homeostasis during Cystic Fibrosis Pulmonary Exacerbation

B. Stanton, Dana B. Dorman, L. A. Moulton, 2012, Clinical and translational science.

Prevalence of Streptococci and Increased Polymicrobial Diversity Associated with Cystic Fibrosis Patient Stability

M. Sogin, H. Morrison, G. O’Toole, 2012, Journal of bacteriology.

Outcome of Critically Ill Allogeneic Hematopoietic Stem-Cell Transplantation Recipients

A. Gifford, Darius Seidler, 2018 .

B. Stanton, T. Hampton, B. Jackson, 2011, Pediatric pulmonology.

Update on Clinical Outcomes of Highly Effective Modulator Therapy.

J. Davies, J. Taylor-Cousar, A. Gifford, 2022, Clinics in chest medicine.

Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials.

Kapil M. Patel, D. Sanders, R. Gibson, 2022, The Lancet. Respiratory medicine.

Nodular Pulmonary Infiltrates in a Patient With Psoriatic Arthritis and Infliximab Therapy

A. Gifford, J. Bessich, 2010 .

Fatal hemoptysis from invasive Aspergillus niger in a patient with cavitary lung disease and Mycobacterium avium complex infection.

A. Gifford, T. Lahey, C. Fordham von Reyn, 2006, Medical mycology.

Prospective use of descriptors of dyspnea to diagnose common respiratory diseases.

D. Mahler, A. Gifford, J. Munson, 2015, Chest.

Need to study simplification of gastrointestinal medication regimen in cystic fibrosis in the era of highly effective modulators

S. Freedman, S. Schwarzenberg, B. Moshiree, 2022, Pediatric pulmonology.

Longevity of Patients With Cystic Fibrosis in 2000 to 2010 and Beyond: Survival Analysis of the Cystic Fibrosis Foundation Patient Registry

Emily A. Knapp, Emily A Knapp, C. Goss, 2014, Annals of Internal Medicine.

Chronic inflammation and lung fibrosis: pleotropic syndromes but limited distinct phenotypes

R. Homer, L. Ghoda, A. Gifford, 2012, Mucosal Immunology.

Calprotectin-Mediated Zinc Chelation Inhibits Pseudomonas aeruginosa Protease Activity in Cystic Fibrosis Sputum

D. Hogan, D. Vermilyea, A. Gifford, 2021, bioRxiv.

Formative evaluation of a dashboard to support coproduction of healthcare services in cystic fibrosis.

E. Nelson, B. Marshall, Cynthia Brady, 2020, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Profiling of Bacterial and Fungal Microbial Communities in Cystic Fibrosis Sputum Using RNA

Nicholas J. Jacobs, M. Sogin, H. Morrison, 2018, mSphere.

Antagonism of substance P and perception of breathlessness in patients with chronic obstructive pulmonary disease

W. Kraemer, B. Kupchak, D. Mahler, 2014, Respiratory Physiology & Neurobiology.

Use of a Multiplex Transcript Method for Analysis of Pseudomonas aeruginosa Gene Expression Profiles in the Cystic Fibrosis Lung

Heather D. Bean, D. Hogan, A. Ashare, 2016, Infection and Immunity.

Use of proton pump inhibitors is associated with lower hemoglobin levels in people with cystic fibrosis

C. Goss, S. Heltshe, A. Gifford, 2021, Pediatric pulmonology.

Autoimmunity to bactericidal/permeability-increasing protein in bronchiectasis exhibits a requirement for Pseudomonas aeruginosa IgG response

K. Winthrop, E. Henkle, A. Gifford, 2019, European Respiratory Journal.

LENALIDOMIDE HYPERSENSITIVITY AND LYMPHOCYTIC PLEURAL EFFUSION: A NOVEL ASSOCIATION

A. Gifford, R. Enelow, L. V. Vusse, 2009 .

Clinical Utility of Prognostic Scoring Systems in Patients with Hematological Malignancies Who Require Mechanical Ventilation

A. Gifford, E. Backer, 2018 .

Does Ivacaftor Taken Twice a Day Keep the Pseudomonas Away?

S. Heltshe, A. Gifford, 2019, Annals of the American Thoracic Society.

The microbiome in pediatric cystic fibrosis patients: the role of shared environment suggests a window of intervention

M. Sogin, H. Morrison, G. O’Toole, 2014, Microbiome.

A Man in His 60s With Shortness of Breath, Shock, and Cardiac Arrest.

Pedro D. Salinas, A. Gifford, 2017, Chest.

Chronic daily respiratory care needs in people with cystic fibrosis treated with highly effective cystic fibrosis transmembrane conductance regulator modulators

A. Gifford, E. Roesch, Katherine E Wajda, 2023, Current opinion in pulmonary medicine.

Iron supplementation does not worsen respiratory health or alter the sputum microbiome in cystic fibrosis.

T. Hampton, Dana B. Dorman, A. Gifford, 2014, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

The microbiome in pediatric cystic fibrosis patients: the role of shared environment suggests a window of intervention

H. Morrison, G. Cutting, B. Stanton, 2014, Microbiome.

Association between CFTR modulators and changes in iron deficiency markers in cystic fibrosis.

J. Taylor-Cousar, A. Gifford, Linda J Fitzgerald, 2024, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Perspectives on anemia and iron deficiency from the cystic fibrosis care community

D. Polineni, A. Gifford, L. Gettle, 2019, Pediatric pulmonology.